Heme Oxygenase-1 Is a cGMP-Inducible Endothelial Protein and Mediates the Cytoprotective Action of Nitric Oxide
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abstract—Inducible heme oxygenase (HO-1) has recently been recognized as an antioxidant and cytoprotective gene. By use of Western blotting, cell viability analysis, and antisense technique, the present study investigates the involvement of HO-1 in endothelial protection induced by the clinically used nitric oxide (NO) donor molsidomine (specifically, its active metabolite 3-morpholinosydnonimine [SIN-1]) and the second messenger cGMP. In bovine pulmonary artery endothelial cells, SIN-1 and S-nitroso-N-acetyl-d,l-penicillamine (SNAP) at 1 to 100 μmol/L induced the synthesis of HO-1 protein in a concentration-dependent fashion up to 3-fold over basal levels. HO-1 induction by SIN-1 was inhibited in the presence of the NO scavenger phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide and the soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one. 8-Bromo-cGMP (1 to 100 μmol/L) and dibutyryl cGMP (1 to 100 μmol/L) as well as the activator of particulate guanylyl cyclase atrial natriuretic peptide (1 to 100 nmol/L) produced increases in HO-1 protein similar to those produced by SIN-1. SIN-1 and 8-bromo-cGMP increased heme oxygenase activity (bilirubin formation). Cytoprotection by NO donors was abrogated in the presence of the heme oxygenase inhibitor tin protoporphyrin IX. Pretreatment of cells with a phosphorothioate-linked HO-1 antisense oligonucleotide prevented protection by SIN-1 or 8-bromo-cGMP against tumor necrosis factor-α cytotoxicity, whereas sense and scrambled HO-1 were without effect under these conditions. Our results show for the first time that HO-1 is a cGMP-sensitive endothelial gene and establish conclusively a causal relationship between HO-1 induction and endothelial protection by the NO/cGMP system. By targeting cytoprotective HO-1, NO donors may therefore be expected to induce antioxidant, antiatherogenic, and anti-inflammatory effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts.
Schröder, H., Leitman, D. C., Bennett, B. M., Waldman, S. A., & Murad, F. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22622-2 · Cited by 85
Cited by
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
“Atrial natriuretic peptide (ANP)-mediated upregulation of HO-1 has been shown to ameliorate the effect of cyclosporine on renal function, presumably via a cGMP-dependent mechanism (Polte et al., 2000).”
Heme oxygenase: colors of defense against cellular stress
Otterbein, L. E., & Choi, A. M. K. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1029 · Cited by 870
Different Faces of the Heme-Heme Oxygenase System in Inflammation
Wagener, F. A. D. T. G., Volk, H.-D., Willis, D., Abraham, N. G., Soares, M. P., Adema, G. J., & Figdor, C. G. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.5 · Cited by 537
Fujita, T., Toda, K., Karimova, A., Yan, S.-F., Naka, Y., Yet, S.-F., & Pinsky, D. J. (2001) · Nature Medicine · doi:10.1038/87929 · Cited by 398
Heme oxygenase and the cardiovascular–renal system
Abraham, N. G., & Kappas, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.010 · Cited by 356
Li, L., Hsu, A., & Moore, P. K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.005 · Cited by 331
Gene regulation of heme oxygenase-1 as a therapeutic target
Immenschuh, S., & Ramadori, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00443-3 · Cited by 301
Heme Oxygenase-1 as a Potential Therapeutic Target for Hepatoprotection
Farombi, E. O., & Surh, Y.-J. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.479 · Cited by 215
Heme Oxygenase-1: From Bench to Bedside
Morse, D., & Choi, A. M. K. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-465so · Cited by 200
“This has since been confirmed by others (80-82) and has led to speculation that HO-1 is in fact responsible for cytoprotective effects attributed to NO.”
ResultCross Talk Between Carbon Monoxide and Nitric Oxide
Hartsfield, C. L. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602753666352 · Cited by 165
“We and other investigators have demonstrated that NO-mediated HO-1 induction is dependent on de novo synthesis of both RNA and protein and occurs via a cGMP-independent signaling pathway (14, 20), although a recent study suggests that NO may act via cGMP to up-regulate HO-1 (39).”
Protective effect of dietary nitrate on experimental gastritis in rats
Larauche, M., Anton, P. M., Garcia-Villar, R., Theodorou, V., Frexinos, J., Buéno, L., & Fioramonti, J. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003845 · Cited by 43
“Results are expressed as means and standard errors of the mean, and differences were considered significant at P,0·05.”
BackgroundMethod
Metadata
- Authors
- Polte, T., Abate, A., Dennery, P. A., & Schröder, H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2000-05
- Volume
- 20
- Issue
- 5
- Pages
- 1209-1215
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2157341713
- Cited by
- 135
- References
- 2
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.